Key Takeaways

Case review comes first, not treatment selection — a free remote review of your records is what actually determines which treatment pathways (CAR-T, surgery, immunotherapy, clinical trials) apply to your specific cancer.

CAR-T total cost of care in China runs $100,000–$150,000 USD, versus $400,000–$500,000+ for the drug alone in the US — but eligibility depends on relapsed/refractory status and confirmed target-antigen expression, not just diagnosis.

Most patients move from first inquiry to treatment start in 3–6 weeks, though complex cases and visa timing can extend this.

Accompanying family members are part of the plan, not an afterthought — accommodation and daily logistics near the hospital are coordinated as part of the process.

All partner hospitals at ChinaCureLink are Grade 3A certified and CAR-T products are NMPA-approved — China's equivalent regulatory rigor to the FDA or TGA.

Introduction

If you're searching for how to get cancer treatment in China, you're probably not asking which treatment you want. You're asking a harder question: what's actually available for your specific case, and how do you find that out.

That's a fair thing to feel stuck on. Most families researching cancer treatment abroad can't tell on their own whether a diagnosis, stage, or treatment history qualifies for something like CAR-T therapy, a clinical trial, or a specialist surgical team in China. This guide is the step-by-step companion to our full Cancer Treatment in China: The Complete Guide for International Patients — that guide covers the full landscape of treatments and hospitals, while this one walks through the process of actually getting there, starting with the step that tells you what's possible rather than the step that assumes you already know.

Step 1 — Get Your Case Reviewed (Free Remote Screening)

Before anything else, your case needs to be reviewed by people qualified to read it.

What to submit

Typically: diagnosis and staging information, pathology reports, imaging (PET/CT, MRI), prior treatment history — including which treatment lines you've already tried — genetic or molecular testing results where relevant, and current medication or discharge records.

For blood cancers specifically, relapsed/refractory status and prior treatment lines matter a great deal. Most CAR-T programs require the patient to have already received two or more prior lines of treatment without achieving durable remission, confirmed target-antigen expression (CD19 for B-cell cancers, BCMA for multiple myeloma) on pathology, and adequate organ function to tolerate pre-conditioning chemotherapy.

A remote case review does two things at once:

• Confirms whether your records are sufficient to make any recommendation at all

• Determines which treatment pathways are realistically available for your specific cancer and stage, matched across our partner hospital network rather than a single facility

Skipping this and researching treatments independently first is a common mistake — it puts you in the position of guessing at options that may not even apply to your case.

Step 2 — Learn Which Treatment Option Applies to You

Once your case has been reviewed, the review itself tells you which of these are realistically on the table:

• CAR-T cell therapy — for eligible blood cancers (relapsed/refractory large B-cell lymphoma, B-ALL, multiple myeloma), typically after prior treatment lines haven't worked. Total cost of care in China generally runs $100,000–$150,000 USD, though the final figure depends on the hospital, treatment complexity, complications, and length of stay. This is significantly lower than the $500,000-$800,000 range that international patients without US insurance typically pay in the United States.

• Surgery — for solid tumors where surgical resection is part of the treatment plan

• Immunotherapy or targeted therapy — PD-1/PD-L1 inhibitors and molecularly targeted agents, depending on genetic markers identified through tumor profiling

• Clinical trial access — for patients who may qualify for trial-based protocols not yet available elsewhere; China currently runs a substantial share of the world's active CAR-T trials

Not every option applies to every cancer or stage. This is why Step 1 has to happen first — the review narrows this list down to what's actually relevant to you, rather than leaving you to guess.

Step 3 — Visa and Travel Planning

Once a treatment pathway is identified, travel logistics begin.

Medical visa basics

Visa requirements depend on your nationality, destination city, and length of stay. Supporting documents typically include a hospital invitation or appointment confirmation, proof of planned admission, and travel itinerary details. Final visa approval is always decided by the relevant embassy or consulate — not by any medical coordination service.

Timeline

Plan in weeks, not days. Most patients move from first inquiry to treatment start in roughly 3–6 weeks, though complex cases can take longer depending on record readiness and visa processing.

Caregiver documentation

If a family member is accompanying you, they may need separate visa documentation. This is typically handled alongside your own travel paperwork.

For general trip logistics beyond the medical process — packing, cultural orientation, and itinerary planning — see How to Plan a Successful Medical Trip to China.

Step 4 — Planning for the Accompanying Family Member

Most patients don't travel alone, and most searches for this topic come from the family member who's about to become a caregiver for several weeks in an unfamiliar country. That deserves real planning, not an afterthought.

Where caregivers stay

Accommodation is usually a hotel or serviced apartment near the treatment hospital, with the choice often depending on how long the stay is expected to run.

Day-to-day logistics

Arranging accommodation, local transport, and daily necessities for the accompanying family member is something ChinaCureLink helps coordinate directly, so the caregiver isn't left to navigate an unfamiliar city alone while also supporting a patient through treatment.

Support during the stay

A bilingual coordinator typically helps with translation, hospital navigation, appointment scheduling, and daily practical questions. This matters because the caregiver is often managing communication, emotional support, and logistics all at once — on top of an unfamiliar language and healthcare system.

The toll of an extended stay

Multi-week stays are demanding, physically and emotionally, for both patient and caregiver. It's worth going into this step with realistic expectations rather than assuming it will feel like a short trip.

Step 5 — What Treatment and Recovery Actually Involve

The first 48 hours after arrival

Hospitals commonly re-check key diagnostics on arrival — bloodwork, imaging, infection screening, and other baseline testing — because medical status can change between the remote review and arrival.

Length of stay by treatment type

Varies significantly. For CAR-T specifically, plan for a minimum of 8-12 weeks at the treatment destination, covering initial consultation and eligibility review (1-2 weeks), cell collection and manufacturing (roughly 3-4 weeks), pre-conditioning chemotherapy (1 week), infusion, and a 2-4 week inpatient monitoring period for side effects, followed by 4-6 weeks of outpatient follow-up. Surgery recovery windows depend on the procedure. These are general ranges — your treatment team will give you a specific estimate once your plan is finalized.

Step 6 — Life After Treatment

Discharge from the hospital doesn't mean the process is over. Ongoing care typically includes:

• Remote follow-up consultations

• Continued scans and bloodwork

• Coordination with your physician back home

• Monitoring for relapse, which varies by cancer type and treatment

Serious cancer treatment requires ongoing follow-up, not a one-time visit. Any pathway you consider should include a plan for what happens after you return home, not just what happens in China.

For a detailed walkthrough of exactly what happens after your case is accepted — from hospital matching through follow-up care — see The ChinaCureLink Process Explained: 7 Steps From Free Case Review to Full Recovery.

How ChinaCureLink Helps at Every Step

Coordinating cancer treatment across borders involves more moving pieces than most families can manage alone. ChinaCureLink handles this end-to-end:

• Case review and hospital matching — your records are reviewed by medically trained coordinators and matched against our partner hospital network, not a single facility

• Translation and interpretation — bilingual medical interpreters for every consultation, so no medical decision is made through a translation app

• Visa and travel logistics — documentation support, invitation letters, and coordination with your treating hospital's international department

• Accompanying family member support — accommodation and daily logistics near the hospital, arranged as part of the process rather than left to the caregiver to figure out

• Post-treatment follow-up — coordination between your Chinese treatment team and your home physician after you return

What Patients Say About ChinaCureLink & Medebound HEALTH

China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.

Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot

Medebound HEALTH's online testimonials. Learn More

★★★★☆   Sarah Zhang  ·  Canada· Jul 2024  ·  Verified

“The interpreter during the video call was fantastic — super professional and answered all our questions clearly and quickly. The professor was also very patient and gave us detailed and honest guidance on our treatment options.”

★★★★★   Andrew Goh  ·  Singapore · Aug 2024  ·  Verified

“My first contact with Medebound was over a year ago. Jason has always been responsive, even when I wasn't ready to proceed. When I finally did, the consultation was seamlessly arranged and the specialist was outstanding.”

★★★★★   Daniel Wong  ·  Singapore · Aug 2024  ·  Verified

“I have dry eye and nothing seemed to be working, even with different medications. I heard about a medication from the U.S. that’s supposed to be really effective, but I didn’t want to try it without talking to a doctor first. MEDEBOUND connected me with a top ophthalmologist in the U.S. and it was so reassuring to get their expert advice.”

★★★★☆   Pongsakorn  ·  Thailand · Feb 2025  ·  Verified

“Kiki at Medebound is amazing — so professional and helpful! They got my video consultation with an MD Anderson expert set up super fast, within just 5 working days. I am so grateful for their support.”

Frequently Asked Questions

Is cancer treatment in China legitimate and safe for international patients?

China has specialist hospitals with significant experience treating international patients, including advanced therapies like CAR-T. All ChinaCureLink partner hospitals are Grade 3A certified — China's highest hospital classification — and CAR-T products used are NMPA-approved, the country's equivalent regulatory body to the FDA or TGA.

How much does cancer treatment cost in China?

It depends heavily on treatment type. CAR-T therapy, for example, generally totals $100,000–$150,000 USD in total cost of care, though the exact figure depends on the hospital, complications, and length of stay. A transparent quote should be provided after your treatment plan is finalized, not before.

How long does the whole process take?

Most patients move from first inquiry to treatment start in about 3–6 weeks, depending on case complexity, record readiness, and visa timing. For CAR-T specifically, plan for a minimum of 8–12 weeks on-site.

Do I need a doctor's referral to start?

No — most patients or families can start directly with a free remote case review by submitting their own medical records.

Can a family member stay with me the whole time, and where do they typically stay?

Yes, many patients travel with a caregiver. Accommodation is typically a hotel or serviced apartment near the hospital, and coordinating those arrangements is part of the support provided during your stay.

What cancers is China known for treating?

China has particular strength in CAR-T therapy for blood cancers such as leukemia, lymphoma, and multiple myeloma, alongside broader oncology surgery, immunotherapy, and clinical trial access for various solid tumors.

References

1. Costs of Care During Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Lymphomas — JNCI Cancer Spectrum / PMC, 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11340641/

2. The Different Classification of Hospitals Impact on Medical Outcomes of Patients in China — PMC, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9339675/

3. Improving Outcomes and Mitigating Costs Associated With CAR T-Cell Therapy — AJMC, 2026. https://www.ajmc.com/view/improving-outcomes-and-mitigating-costs-associated-with-car-t-cell-therapy

About ChinaCureLink

ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.

We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.

ChinaCureLink is proudly affiliated with Medebound HEALTH — an international medical concierge company headquartered in New York, specialized in securing premium second opinions from top US hospitals and specialists. With over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized as one of the leading patient access services across North America and the Asia-Pacific, bringing the same standard of expert care coordination to every patient we serve.

This article is for informational purposes only and does not constitute medical advice. All treatment decisions should be made in consultation with a qualified oncologist who has reviewed your complete medical history and current diagnostic information.

Meta title: How to Get Cancer Treatment in China: Step-by-Step Guide

Meta description: How to get cancer treatment in China: case review, CAR-T eligibility ($100K–$150K), visa steps, and caregiver planning — a 6-step patient guide.